CLINICAL EVALUATION OF GENE MUTATIONS IN K-RAS PATIENTS WITH COLORECTAL CANCER

Abstract. One of the most significant events in the molecular pathogenesis of colorectal cancer is a mutation in the gene K-ras. Data on the prognostic significance of tumor gene mutations are contradictory and are subject to debate.

Objective ― to investigate the relationship mutations in K-ras with the clinical morphological parameters of the tumor to identify the factors influencing the course and prognosis of the disease.

The study included 120 patients with colorectal cancer who received a combination treatment.

Results. The presence of mutations in K-ras gene in colorectal cancer is more common in younger patients, females, the representatives of Russian nationality. Tumors with mutations in K-ras gene frequently metastasize to regional lymph nodes and give distant metastasis. Patients with mutation in K-ras gene have lower one-year survival.

Key words: colorectal cancer, K-ras gene.

 

I.G. Gataullin1, M.G. Gordiev2, R.K. Shakirov2, B.I. Gataullin1

1Kazan State Medical Academy, Kazan

2Tatarstan Cancer Center, Kazan

3Volga Region branch of N.N. Blokhin Russian Cancer Research Center, Kazan

 

Gataullin I.G. ― D. Med. Sc., Professor of the Department of oncology, radiology and palliative medicine in Kazan State Medical Academy

29 Sibirskiy Trakt, Kazan, Russian Federation, 420029, tel. (843) 519-26-86, e-mail: ilgizg@list.ru